Structure Therapeutics (GPCR) EBT (2022 - 2026)
Structure Therapeutics (GPCR) recorded quarterly EBT of -$75.8 million in Q1 2026, down 142.75% quarter-over-quarter from $177.3 million in Q4 2025, and down 62.14% on a YoY basis from -$200.2 million in Q1 2025.
Structure Therapeutics (GPCR) EBT (2022 - 2026) Analysis & Trends
Structure Therapeutics' EBT history runs 5 years deep, the most recent figure standing at -$75.8 million for Q1 2026.
- In Q1 2026, EBT fell 62.14% year-over-year to -$75.8 million; the TTM figure through Mar 2026 stood at -$25.7 million (up 80.83% YoY), while the FY2025 annual figure was $3.4 million, up 103.0% from the prior year.
- EBT was -$75.8 million for Q1 2026 at Structure Therapeutics, down from $177.3 million in the prior quarter.
- In the past five years, EBT ranged from a high of $177.3 million in Q4 2025 to a low of -$75.8 million in Q1 2026.
- Historically, EBT has averaged -$14.1 million across 5 years, with a median of -$23.5 million in 2023.
- The sharpest annual moves came in 2023 and 2024: EBT surged 1199.62% in 2023, then sank 149.44% in 2024.
- A 5-year view of EBT shows it stood at -$5.0 million in 2022, then soared by 1199.62% to $55.1 million in 2023, then tumbled by 149.44% to -$27.2 million in 2024, then surged by 750.84% to $177.3 million in 2025, then sank by 142.75% to -$75.8 million in 2026.
- The last three EBT figures came in at -$75.8 million (Q1 2026), $177.3 million (Q4 2025), and -$65.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.31 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.18 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.48 Mn |
| 10 | Structure Therapeutics | 9.35 Bn | 9.35 Bn | - | -75.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.78 Mn |
| Dec 31, 2025 | 177.25 Mn |
| Sep 30, 2025 | -65.60 Mn |
| Jun 30, 2025 | -61.52 Mn |
| Mar 31, 2025 | -46.74 Mn |
| Dec 31, 2024 | -27.23 Mn |
| Sep 30, 2024 | -33.89 Mn |
| Jun 30, 2024 | -25.98 Mn |
| Mar 31, 2024 | -26.01 Mn |
| Dec 31, 2023 | 55.08 Mn |
| Sep 30, 2023 | -23.46 Mn |
| Jun 30, 2023 | -23.16 Mn |
| Mar 31, 2023 | -17.95 Mn |
| Dec 31, 2022 | -5.01 Mn |
| Sep 30, 2022 | -12.34 Mn |
| Jun 30, 2022 | -13.88 Mn |
| Mar 31, 2022 | -13.02 Mn |